Digipath Labs Submit Plan of Correction in Response to License Suspension

On January 22 Digipath announced that it would submit a Plan of Correction to the State of Nevada's Department of Taxation, Marijuana Enforcement Division, addressing regulatory violations the Department found in the course of its review of Digipath Labs' operations and procedures.  Digipath Labs was notified by the Department on January 19, 2018, following the close of business, that the Medical Marijuana Registration Certificate and Marijuana Testing Facility License held by its wholly-owned subsidiary, Digipath Labs, had been suspended.  The Department's notice provides for a hearing before an administrative law judge on February 15, 2018. Digipath is seeking reinstatement of its licenses as soon as possible so that it can resume its testing services.

Mr. Todd Denkin, President and COO of Digipath, Inc., stated, "We remain committed to the health and safety of the public and have always taken our role seriously as the gatekeeper between producers and consumers, to provide a valid certificate of analysis on all cannabis products coming through our lab prior to reaching the public.  We are grateful to the Department of Taxation for their input and are working aggressively with state regulators to correct all of the issues raised by their review of our operations." "We have communicated with our clients, who are supportive of our company, and assured them that until the resolution of this matter, Digipath Labs will work with other testing laboratories to ensure that our clients' testing needs are met."